The 3 most recent market catalysts affecting $V2X, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 92
V2X shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
This headline is a major corporate catalyst, directly impacting V2X's stock price. Better-than-expected earnings and raised guidance signal strong operational performance and a pos…
Jul 21, 2026
Corporate Catalyst
Bullish
Impact 75
V2X shares are trading higher after the company announced it will replace Avanos Medical in the S&P SmallCap 600 effective prior to the opening of trading on Monday, July 27.
The inclusion of V2X in the S&P SmallCap 600 is a significant corporate catalyst. This typically leads to increased demand for the stock from passive index funds and ETFs that trac…
Jul 20, 2026
Market Technicals
Neutral
Impact 55
V2X To Replace Avanos Medical In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, July 27
The filing indicates a change in the S&P SmallCap 600 index composition, with V2X replacing Avanos Medical. This is a technical event that will primarily affect passive investment …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.